File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

TitleTenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Authors
Chan, HLFung, SSeto, WKWChuang, WLChen, CYKim, HJHui, AJJanssen, HChowdhury, ATsang, TYRajiv, MGane, EFlaherty, JMassetto, BGaggar, AKitrinos, KMLin, LSubramanian, GMMcHutchison, JLim, YSAcharya, SKAgarwal, K
Issue Date2016
Citation
The Lancet Gastroenterology & Hepatology, 2016, v. 1, p. 185-195 How to Cite?
DOI: http://dx.doi.org/10.1016/S2468-1253(16)30024-3
Persistent Identifierhttp://hdl.handle.net/10722/237763
ISI Accession Number ID
WOS:000438434000018

 

DC FieldValueLanguage
dc.contributor.authorChan, HL-
dc.contributor.authorFung, S-
dc.contributor.authorSeto, WKW-
dc.contributor.authorChuang, WL-
dc.contributor.authorChen, CY-
dc.contributor.authorKim, HJ-
dc.contributor.authorHui, AJ-
dc.contributor.authorJanssen, H-
dc.contributor.authorChowdhury, A-
dc.contributor.authorTsang, TY-
dc.contributor.authorRajiv, M-
dc.contributor.authorGane, E-
dc.contributor.authorFlaherty, J-
dc.contributor.authorMassetto, B-
dc.contributor.authorGaggar, A-
dc.contributor.authorKitrinos, KM-
dc.contributor.authorLin, L-
dc.contributor.authorSubramanian, GM-
dc.contributor.authorMcHutchison, J-
dc.contributor.authorLim, YS-
dc.contributor.authorAcharya, SK-
dc.contributor.authorAgarwal, K-
dc.date.accessioned2017-01-20T02:28:12Z-
dc.date.available2017-01-20T02:28:12Z-
dc.date.issued2016-
dc.identifier.citationThe Lancet Gastroenterology & Hepatology, 2016, v. 1, p. 185-195-
dc.identifier.urihttp://hdl.handle.net/10722/237763-
dc.languageeng-
dc.relation.ispartofThe Lancet Gastroenterology & Hepatology-
dc.titleTenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial-
dc.typeArticle-
dc.identifier.emailSeto, WKW: wkseto2@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.doi10.1016/S2468-1253(16)30024-3-
dc.identifier.pmid28404091-
dc.identifier.scopuseid_2-s2.0-84996520524-
dc.identifier.hkuros270978-
dc.identifier.volume1-
dc.identifier.spage185-
dc.identifier.epage195-
dc.identifier.isiWOS:000438434000018-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats